Additionally, dual-incretin therapies that activate both GLP-1 and GIP (glucose-dependent insulinotropic peptide) receptors are now available
Sermorelin is sometimes marketed for weight loss, but strong clinical studies have not shown meaningful benefits for obesity, visceral fat reduction, or GLP-1-related muscle preservation
Afamelanotide mostly hits MC1R and is FDA-approved for a rare skin condition called erythropoietic protoporphyria
However, not all clinics maintain proper protocols or use high-quality ingredients, making it essential to choose the right provider
PRDM16-DT is a novel lncRNA that regulates astrocyte function in Alzheimers disease
Only three semaglutide drugs are approved by the FDA, including Ozempic, Wegovy, and Rybelsus, while in India, the Drugs Controller General of India (DCGI) has approved only Novo Nordisk's oral semaglutide (Rybelsus)